Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1997-5-29
pubmed:abstractText
Impairment of splanchnic and peripheral tissue perfusion during cardiopulmonary bypass (CPB) may be responsible for endotoxin-mediated systemic inflammation and acute phase responses. We examined the effects of dopexamine on hemodynamic parameters, creatinine clearance, systemic and splanchnic oxygenation, gastric mucosal pH (pHi), and mixed and hepatic venous plasma levels of endotoxin, interleukin-6 (IL-6), serum amyloid A (SAA), and C-reactive protein (CRP) in 44 patients scheduled for coronary artery bypass grafting. Patients were randomized to receive continuous infusions of 0.5, 1.0, or 2 micrograms.kg-1.min-1 dopexamine (n = 10 per group) or placebo (n = 14) prior to surgery, intraoperatively, and postoperatively. Dopexamine infusion increased systemic oxygen delivery (P < or = 0.01). Hepatic venous oxygen saturation did not change, and pHi decreased during and after CPB in all patients (P < or = 0.01). Postoperative increases in IL-6 were smallest in patients who received 2.0 micrograms.kg-1.min-1 dopexamine (P < or = 0.02). SAA and CRP increases during the postoperative period were less pronounced with dopexamine throughout the study. Creatinine clearance was elevated in all dopexamine groups (P < or = 0.025). This elevation was higher with lower dopexamine doses (P < or = 0.025). We conclude that dopexamine improves creatinine clearance and reduces systemic inflammation without affecting splanchnic oxygenation.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0003-2999
pubmed:author
pubmed:issnType
Print
pubmed:volume
84
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
950-7
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:9141914-Acute-Phase Reaction, pubmed-meshheading:9141914-Adrenergic beta-Agonists, pubmed-meshheading:9141914-C-Reactive Protein, pubmed-meshheading:9141914-Cardiopulmonary Bypass, pubmed-meshheading:9141914-Coronary Artery Bypass, pubmed-meshheading:9141914-Creatinine, pubmed-meshheading:9141914-Dopamine, pubmed-meshheading:9141914-Endotoxins, pubmed-meshheading:9141914-Female, pubmed-meshheading:9141914-Hemodynamics, pubmed-meshheading:9141914-Hepatic Veins, pubmed-meshheading:9141914-Humans, pubmed-meshheading:9141914-Hydrogen-Ion Concentration, pubmed-meshheading:9141914-Interleukin-6, pubmed-meshheading:9141914-Kidney, pubmed-meshheading:9141914-Lactic Acid, pubmed-meshheading:9141914-Male, pubmed-meshheading:9141914-Middle Aged, pubmed-meshheading:9141914-Oxygen, pubmed-meshheading:9141914-Prospective Studies, pubmed-meshheading:9141914-Serum Amyloid A Protein, pubmed-meshheading:9141914-Splanchnic Circulation
pubmed:year
1997
pubmed:articleTitle
Effects of dopexamine on creatinine clearance, systemic inflammation, and splanchnic oxygenation in patients undergoing coronary artery bypass grafting.
pubmed:affiliation
Department of Anesthesiology and Intensive Care Medicine, University of Münster, Germany.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial